Dylan Bird

GenapSys, Inc. develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing. It also develops gene electronic nano-integrated ultra-sensitive platform device for chip-based DNA sequencing. The company was founded by Hesaam Esfandyarpour in 2010 and is headquartered in Redwood, CA.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL.

Pan Pacific Pharmaceuticals, Inc. manufactures pharmaceutical preparations. The private company is based in Lincoln, RI. The company was founded by Xiang Ming Cui.

Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.

Shenzhen GeneMDx Biotech Co., Ltd. manufactures biologique products. It engages in domestic sales of medical equipments and diagnosis reagents. The company was founded on June 23, 2011 and is headquartered in Shenzhen, China.

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016.

Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore.

Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA.

Nanjing Bioheng Biotech Co., Ltd. specializes in novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. The company was founded by Xiao Hong He on March 27, 2017 and is headquartered in Nanjing, China.

Shanghai Ketai Medical Device Co., Ltd. is a medical device company founded in 2013. The company is based in Shanghai, China. The Chinese company's description is in non-English characters, but it appears to be related to medical devices and technology.

Levitasbio, Inc. provides redefining cellular analytics with its novel platform magnetic levitation technology. The company was founded by Utkan Demirci, Lars Steinmetz and Gozde Durmus and is headquartered in Menlo Park, CA.

Ariagen, Inc. provides investment services. The CEO of the American company is Peter Colabuono.

ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA.